Document:

exv10w19

 

EXHIBIT 10.19

CONFIDENTIAL TREATMENT REQUESTED

LONGRUN2 TECHNOLOGY LICENSE AGREEMENT

     This LongRun2 Technology License Agreement (“Agreement”) is made and entered into as of
January 20, 2005 (“Effective Date”), by and between Transmeta Corporation, a Delaware corporation
having its principal place of business at 3990 Freedom Circle, Santa Clara, CA 95054, U.S.A.
(“Transmeta”), and Sony Corporation (“Sony”), a Japanese corporation having its principal place of
business at 6-7-35 Kitashinagawa, Shinagawa-ku, Tokyo 141-0001, Japan (“Sony”).

RECITALS

     A. Transmeta develops and sells software-based microprocessors and related hardware and
software technologies.

     B. Transmeta has developed certain proprietary power management and related technologies,
including Transmeta Technology (as defined below).

     C. Sony desires that Transmeta grant Sony a license under Transmeta’s Intellectual Property
Rights (as defined below) in and to the Transmeta Technology, and Transmeta is willing to grant
Sony such a license, subject to and in accordance with the terms and conditions of this Agreement,
for Sony to use the Transmeta Technology with its * * * CMOS technology generations, and any
intermediate (i.e., internode) generations thereof.

     D. Sony desires that Transmeta provide Sony with certain technology transfer and technical
support services related to the Transmeta Technology and Transmeta is willing to provide Sony with
such services, subject to and in accordance with the terms of this Agreement.

     NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:

	1.  	DEFINITIONS
	 
	1.1  	“Foundry Service” means the service of manufacturing semiconductor wafers on behalf of third
parties where the manufacturer provides the third parties with process information (such as
design rules) and/or cell libraries, function block or macro (such as, by way of example, but
not limitation, a digital or analog block or cell library) to be incorporated into the wafers.
	 
	1.2  	"Have Manufactured” means for Sony (or a sublicensed Sony Subsidiary (as defined below))
to contract with a third party or parties to perform designing or manufacturing functions for
and on behalf of Sony (or the sublicensed Sony Subsidiary).

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	1
	 	January 2005

 

 

	1.3  	“Intellectual Property Rights” means patent rights (including patent applications and
disclosures), mask work rights, copyrights, rights in trade secrets and know-how, and any
other intellectual property rights recognized in any country or jurisdiction in the world,
exclusive of rights in and to trademarks, trade names, logos, service marks, other
designations of source and design patents and design patent applications.
	 
	1.4  	“LongRun2 Products” means CMOS integrated circuit semiconductor devices that are based on,
manufactured utilizing, embody, implement, incorporate or practice the Transmeta Technology,
in whole or in part.
	 
	1.5  	“Patent(s)” means any patent(s) or patent application(s), worldwide, owned or controlled by a
party at any time during the term of this Agreement, except for design patents and design
patent applications.
	 
	1.6  	“Sony Improvements” means any improvements, modifications, enhancements, extensions to or
derivative works directly based upon the Transmeta Technology, in whole or in part, developed
by or for Sony or a Sony Subsidiary by any employee, contractor, consultant or agent of Sony
or a Subsidiary who has had access to Transmeta Technology pursuant to this Agreement or the
Mutual NDA (defined in Section 3.1).
	 
	1.7  	“Subsidiary” means any entity that a party controls. For purpose of this definition,
“controls” means having: (i) ownership of more than fifty percent (50%) of the equity
securities entitled to vote for the election of directors (or, in the case of an entity that
is not a corporation, for the election of the corresponding managing authority); or (ii) the
right to vote for or appoint a majority of the board of directors or other governing body of
such entity. Any entity will be deemed to be a “Subsidiary” only so long as such control
exists. Subsidiary(ies) of Sony will be referred to as “Sony Subsidiary(ies)” and those of
Transmeta will be referred to as “Transmeta Subsidiary(ies)”.
	 
	1.8  	“Transmeta Technology” means Transmeta’s proprietary power management and related
technologies described in Exhibit A attached hereto, and including any improvements,
modifications, enhancements, extensions thereto or derivative works based thereon, in whole or
in part, developed by or for Transmeta or Transmeta Subsidiaries, that Transmeta provides to
Sony pursuant to the terms of this Agreement.
	 
	1.9  	“Transmeta Technology Deliverables” means those items of Transmeta Technology specified in
Exhibit A, attached hereto, that Transmeta will deliver to Sony in accordance with the
terms of this Agreement.
	 
	1.10  	“Transmeta Documents” means the documents included in the Transmeta Technology Deliverables
specified in Exhibit A, attached hereto, that Transmeta will deliver to Sony pursuant
to the terms of this Agreement.

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	2
	 	January 2005

 

 

	2.  	LICENSES, LICENSE ROYALTIES AND NON-ASSERTION RIGHTS
	 
	2.1  	License Grant. Subject to Sony’s compliance with all of the terms and conditions of
this Agreement (including, without limitation, timely payment of all applicable fees,
royalties and any other amounts payable hereunder), Transmeta hereby grants to Sony a
worldwide, nonexclusive, nontransferable (except as specified in Section 12.1),
non-sublicensable (except as specified in Section 2.2) and royalty-bearing license under all
of Transmeta’s Intellectual Property Rights in and to Transmeta Technology to:

	 	(a)  	use, reproduce and create Sony Improvements based upon the
Transmeta Technology for Sony and third-party customers of Sony, solely for the
purpose of designing and developing LongRun2 Products for * * * CMOS
semiconductor technology generations (and any intermediate (i.e., internode)
generations thereof) (“Licensed LongRun2 Products”);
	 
	 	(b)  	manufacture (and Have Manufactured), use, offer for sale, sell,
or import Licensed LongRun2 Products; and
	 
	 	(c)  	use, reproduce, modify, translate, summarize and distribute the
Transmeta Documents, provided that Sony will comply with the confidentiality
obligations hereunder to the extent Transmeta Confidential Information (as
defined below) is included.

	   	It is acknowledged and agreed by the parties that the rights and license granted under this
Section expressly include the right and license for Sony to utilize any Transmeta Technology
to provide Foundry Services to any third-party customers of Sony in order for such
third-party customers to design and develop Licensed LongRun2 Products for exclusive
manufacture by Sony solely for such third-party customers, and to use, offer for sale, sell,
or import such Licensed LongRun2 Products.
	 
	2.2  	Sony Subsidiaries. Sony has the right to sublicense any (or all) of the license
rights granted in Section 2.1 to any Sony Subsidiary. Sony, however, hereby guarantees the
compliance by each and every such Sony Subsidiary with the terms and conditions of this
Agreement, and Sony and such Sony Subsidiaries shall be jointly and severally liable for any
breach thereof by any such Sony Subsidiary.
	 
	2.3  	License Restrictions.

	 	(a)  	Restrictions on Have Manufactured Rights. Sony
acknowledges that any exercise of its “Have Manufactured” rights under Section
2.1 is expressly contingent upon Sony entering into a written agreement with
its contract designer(s) or manufacturer(s) for the design or manufacture of
Licensed LongRun2 Products (a “Contract Manufacturing Agreement”). Each
Contract Manufacturing Agreement that Sony enters into shall contain provisions
that protect

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	3
	 	January 2005

 

 

	 	   	Transmeta’s Intellectual Property Rights in and to the Transmeta
Technology, Transmeta Technology Deliverables and Transmeta Confidential
Information to at least the same extent as the terms and conditions of this
Agreement. Sony will use its commercially reasonable efforts to enforce each
such Contract Manufacturing
Agreement with at least the same degree of diligence used by Sony to enforce
similar agreements for its own products. Sony will promptly notify
Transmeta in writing of any breach of any such Contract Manufacturing
Agreement by a Sony contract designer or manufacturer relating to the
Transmeta Technology, Transmeta Technology Deliverables or Transmeta
Confidential Information of which Sony becomes aware. Sony will be liable
for any and all losses or damages of any kind suffered or incurred by
Transmeta arising out of or relating to any such breach.
	 
	 	(b)  	Specific Restrictions. Without limiting any
restrictions or other limitations specified in Section 2.3(a) above, Sony
further acknowledges that, in no event shall Sony or a sublicensed Sony
Subsidiary authorize or permit a Sony contract designer or manufacturer to
design, manufacture, use, offer to sale, sell, or import a Licensed LongRun2
Product for or on behalf of any party other than Sony or a sublicensed Sony
Subsidiary, as applicable.
	 
	 	(c)  	Limited Rights. Sony’s rights in the Transmeta
Technology, Transmeta Technology Deliverables and Transmeta Confidential
Information will be limited to those expressly granted in this Agreement.
Transmeta reserves all rights in and to the Transmeta Technology, Transmeta
Technology Deliverables and Transmeta Confidential Information not expressly
granted to Sony hereunder. For the avoidance of doubt, Sony acknowledges and
agrees that it may not use, reproduce, or create Sony Improvements based upon
the Transmeta Technology, Transmeta Technology Deliverables or Transmeta
Confidential Information, or manufacture (or Have Manufactured), offer for
sale, sell, or import any products, except as expressly authorized in this
Agreement.

	2.4  	Royalties. For each Licensed LongRun2 Product manufactured by or for Sony or
sublicensed Sony Subsidiaries, Sony will pay Transmeta the non-refundable royalties calculated
in accordance with the royalty schedule set forth in Exhibit D. Royalties shall
accrue upon the date of completion of sale of each Licensed LongRun2 Product. Within * * *
after: (i) the end of each calendar quarter during the term of this Agreement in which the
royalty accrues and (ii) the termination of this Agreement, Sony shall submit to Transmeta the
payment of royalties due as shown in the Royalty Report (as defined in Section 5.2 below).

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	4
	 	January 2005

 

 

	2.5  	Non-Assertion by Sony of Patent Rights in Sony Improvements. Subject to Transmeta’s
compliance with all of the terms and conditions of this Agreement, Sony, on behalf of itself
and all sublicensed Sony Subsidiaries, hereby covenants not to sue for infringement of or
otherwise assert rights in any of its Patents which are filed for the inventions generated
from Sony Improvements against:

	 	(a)  	Transmeta and Transmeta Subsidiaries on the grounds that they
are making, using, selling, offering for sale, importing LongRun2 Products, but
only with respect to those features, techniques or functionalities of a
LongRun2 Product that implement, incorporate, embody or are based on a Sony
Improvement.
	 
	 	(b)  	distributors and customers (including but not limited to
end-user customers) of Transmeta and Transmeta Subsidiaries on the grounds that
such parties are using, selling, offering for sale, or importing LongRun2
Products manufactured by or for Transmeta or Transmeta Subsidiaries, but only
with respect to those features, techniques or functionalities of a LongRun2
Product. and
	 
	 	(c)  	contract manufacturers of Transmeta and Transmeta Subsidiaries
on the grounds that such manufacturers are manufacturing LongRun2 Products
solely for Transmeta or Transmeta Subsidiaries, but only with respect to those
features, techniques or functionalities of a LongRun2 Product that implement,
incorporate, embody or are based on a Sony Improvement.

	   	In the event that this Agreement is assigned by Transmeta to a third party, Sony’s or
Sony Subsidiaries’ Patents which are subject matters of this Section 2.5 shall be limited to
those implemented in the LongRun2 Products which have been manufactured by or for Transmeta
or Transmeta Subsidiaries as of the date of such assignment.
	 
	2.6  	Additional Patent Licensing. At Transmeta’s request, at any time during the term of
this Agreement, Sony will negotiate with Transmeta in good faith (but not be obligated to
agree to) the granting of a license under any Sony Patent related to Transmeta’s LongRun2
Products. The terms of such license, if agreed upon, will be documented in a separate
agreement.
	 
	3.  	TECHNOLOGY TRANSFER SERVICES AND FEES
	 
	3.1  	Transmeta Obligations: Subject to Sony’s payment of the technology transfer services
fee in accordance with Section 3.5 below, during the * * * period following the Effective Date
(the “Technology Transfer Services Period”), Transmeta will deliver to Sony: (i) the Transmeta
Technology Deliverables as set forth in Exhibit A; and (ii) certain technology
training as set forth in Exhibit A in accordance with the terms specified therein
(“Technology Transfer Training”) as soon as can be mutually

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	5
	 	January 2005

 

 

	   	agreed. Transmeta will make delivery of the items identified in * * * of Exhibit A within * * * after the
execution of this Agreement. Items identified in * * * of Exhibit A will be
delivered as soon as * * *. The parties acknowledge that items identified in * * * of
Exhibit A have been delivered by Transmeta to Sony in accordance with that certain
Mutual Non-Disclosure Agreement * * *. (the “Mutual NDA”) Unless otherwise agreed in writing
between the parties, Transmeta will have no obligation to provide additional deliverables or
training of any kind after the expiration of the Technology Transfer Services Period.
	 
	3.2  	Technical Support Services and Maintenance Services. At Sony’s request, and subject
to Transmeta’s mutual agreement, and subject to Sony’s payment of the applicable fees in
accordance with Section 3.6, during the term of this Agreement, Transmeta will provide or make
available to Sony the technical support services, as specified in Exhibit B
(“Technical Support Services”), and the maintenance services, as specified in Exhibit
B (“Maintenance Services”). Notwithstanding the foregoing, Sony may cancel Technical
Support Services and Maintenance Services, at any time, upon at least * * * prior written
notice.

	3.3  	Provision of Transmeta Technology “AS IS”. The Transmeta Technology, Transmeta
Technology Deliverables, Technology Transfer Training, Technical Support Services and
Maintenance Services are provided “AS IS”.

	3.4  	Acknowledgement of Confidential Information. Sony acknowledges that the Transmeta
Technology, Transmeta Technology Deliverables, Technology Transfer Training, Technical Support
Services and Maintenance Services contain and will disclose to Sony certain highly valuable
trade secrets of Transmeta unless and until those falls into any of the exceptions as provided
in Section 7.3 below.

	3.5  	Technology Transfer Services Fee. In consideration of Transmeta’s delivery of the
Transmeta Technology Deliverables and Technology Transfer Training pursuant to Section 3.1
during the Technology Transfer Services Period, Sony will pay Transmeta a one-time technology
transfer fee of * * * in accordance with the payment schedule set forth in Exhibit C.
The technology transfer fee payable by Sony hereunder is non-refundable and non-recoupable,
and is not creditable against the royalties which may become payable by Sony under Section
2.4. This payment is in no way dependent upon Sony successfully manufacturing a Licensed
LongRun2 Product or “bringing up” a Licensed LongRun2 Product production process.

	3.6  	Technical Support Services and Maintenance Services Fee. In consideration of
Transmeta providing Technical Support Services and Maintenance Services pursuant to Section
3.2, Sony will pay Transmeta a fee in accordance with the payment schedule set forth in
Exhibit B. The fees for Technical Support Services and Maintenance Services payable
by Sony hereunder are non-refundable and non-recoupable, and are not creditable against the
royalties which may become payable by Sony under Section 2.4. If Sony cancels Technical
Support Services and Maintenance Services in accordance with the provisions of Section 3.2,
the fees payable by Sony

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	6
	 	January 2005

 

 

	   	will be pro-rated based on the period for which Transmeta has
performed (and continues to perform) such Technical Support Services or Maintenance Service
until such scheduled cancellation date.
	 
	4.  	PAYMENT, INTEREST AND TAXES
	 
	4.1  	Payment Method. All payments by Sony shall be made in U.S. dollars by wire transfer
to the bank account to be separately designated in writing by Transmeta.
	 
	4.2  	Interest and Other Payment Terms. Any payments made after the applicable due date
will incur interest at the rate of * * *. All amounts specified in this Agreement will be
paid in U.S. dollars and will not be subject to setoff against any amounts of claims that
Transmeta owes to Sony under this Agreement or under any other agreement.
	 
	4.3  	Taxes. Sony will pay any and all national, state, prefecture, city, local and other
excise, sales, use, value-added and other taxes and duties imposed by any and all applicable
laws and regulations in Japan in respect of the payments made under this Agreement or
otherwise arising out of this Agreement, other than taxes based upon Transmeta’s net income.
If it is required under applicable law, Sony may pay, on Transmeta’s behalf, any withholding
taxes that are required to be paid under applicable law. In this event, Sony will furnish
Transmeta with written documentation of such payments, including but not limited to receipts,
of any and all such taxes paid by Sony.
	 
	5.  	RECORDS AND AUDIT REQUIREMENTS
	 
	5.1  	Records. For * * * after the completion of each calendar quarter, Sony will maintain
complete and accurate books, records and accounts as are reasonably necessary to verify the
royalty payments made by Sony hereunder.
	 
	5.2  	Reports. Within * * * after (i) the end of each calendar quarter during the term of
this Agreement; and (ii) the termination of this Agreement, Sony will furnish to Transmeta a
written report specifying the royalties owed for the relevant period (“Royalty Report”). If
no royalties are due, that fact will be shown on such Royalty Report. The content, form and
format of such Royalty Reports will be as mutually agreed to by the parties, but will include,
at a minimum, the quantity of each royalty-bearing Licensed LongRun2 Product.
	 
	5.3  	Audit. During the term of this Agreement and for a period of * * * thereafter, upon
at least * * * prior written notice to Sony, Transmeta will have the right, at its own cost
and expense, to authorize a certified public accounting firm as agreed by Sony, with Sony’s
prior consent which will not be unreasonably withheld or delayed, to audit Sony’s books,
records, and accounts, and other relevant information for the purpose of verifying the
accuracy of the amount of royalties reported by Sony in Royalty Reports pursuant to Section
5.2, provided that such audit shall be conducted during the normal business hours of Sony and
no more frequently than once a year. If the

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	7
	 	January 2005

 

 

	   	accounting firm concludes that additional amounts
were owed during the audited period, Sony will pay such additional amounts plus interest
calculated in accordance with Section 4.2, within * * * of the date Transmeta delivers the
accounting firm’s written report to Sony. Transmeta will pay the fees and expenses charged by
the accounting firm; provided however, if the audit discloses that the royalties payable by
Sony for the audited period are more than * * * of the amounts actually paid for such period,
then Sony will pay the reasonable fees and expenses charged by the accounting firm.
	 
	6.  	TERM AND TERMINATION
	 
	6.1  	Term. This Agreement will begin on the Effective Date and will remain in force * * *
unless and until terminated in accordance with Section 6.2. Notwithstanding the foregoing,
this Agreement will automatically extend for additional * * * periods unless Sony notifies
Transmeta in writing at least * * * prior to the then applicable expiration date that Sony
does not want this Agreement to extend. At Sony’s request, at the time of any extension of
this Agreement, Transmeta will negotiate with Sony in good faith revision of terms and
conditions of this Agreement, including, but not limited to discount of the royalty.
	 
	6.2  	Termination. Either party may terminate this Agreement: (i) if the other party
breaches any material term or condition of this Agreement that is curable and fails to cure
such breach within * * * following receipt of written notice from the
non-breaching party; or (ii) immediately upon written notice to the other party if such other
party breaches any material term or condition of this Agreement that is not curable.
	 
	6.3  	Effect of Termination. Upon the termination of this Agreement by either party
pursuant to Section 6.2: (i) except as otherwise expressly provided in this Agreement,
all licenses and rights granted to Sony hereunder will immediately terminate; (ii) Sony
shall promptly return to Transmeta or destroy all Transmeta Confidential Information and all
Transmeta Technology Deliverables in its possession or control and provide Transmeta with an
officer’s written certification, certifying to the return or destruction of all such
Transmeta Confidential Information and Transmeta Technology Deliverables, provided that Sony
(and sublicensed Sony Subsidiaries) may retain a reasonable number of copies thereof
necessary for the provision of maintenance services to its then existing customers to which
Sony and/or Sony Subsidiaries had already sold the Licensed LongRun2 Products; and (iii)
Transmeta shall promptly return to Sony or destroy all of Sony Confidential Information
that Transmeta may have obtained through the course of this Agreement, and provide Sony with
an officer’s written certification, certifying to the return or destruction of all such
Confidential Information.
	 
	6.4  	Survival. Sony’s obligation to pay any accrued unpaid amounts due to Transmeta will
survive termination of this Agreement in case of termination for any reason. The rights and
obligations of the parties under Sections 1, 2.3, 2.5 (except if Sony

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	8
	 	January 2005

 

 

	   	terminates this
Agreement pursuant to Section 6.2), 3.3, 3.4, 4, 5, 6.3, 6.4, 7, 8, 9, 10, 11 and 12 of this
Agreement also will survive the termination of this Agreement for any reason. The license
rights granted by Transmeta under Sections 2.1 and 2.2 will survive termination of this
Agreement by either party pursuant to Section 6.2 with respect to any and all Licensed
LongRun2 Products sold and invoiced by Sony or a sublicensed Sony Subsidiary prior to the
effective date of termination and, subject to Sony’s payment of the applicable royalties in
accordance with the terms of this Agreement, any Licensed LongRun2 Products manufactured by
Sony or a sublicensed Sony Subsidiary prior to the effective date of termination.
Notwithstanding the foregoing, Section 2.5 will survive termination only to the extent of
Sony’s or Sony Subsidiaries’ Patents which are implemented in the LongRun2 Products which have
been manufactured by or for Transmeta or Transmeta Subsidiaries as of the date of such
termination.
	 
	6.5  	Confirmation of Sony’s License Rights. The parties acknowledge that the Transmeta
Technology is “intellectual property” as defined in Section 101(56) of the U.S. Bankruptcy
Code (the “Code”), that this Agreement is governed by Section 365(n) of the Code, and that
Sony will have the right to exercise all rights provided by Section 365(n) of the Code with
respect to the Transmeta Technology. Without limiting the foregoing, the parties agree that
in the event that any bankruptcy proceeding is filed by or against Transmeta, and the
bankruptcy trustee or debtor-in-possession rejects this Agreement, Sony will have the right to
exercise all rights provided by Section 365(n) of the Code, including the right to retain its
license rights to the Transmeta Technology under this Agreement and any agreement ancillary to
this Agreement, subject to Sony’s ongoing payment of any royalties payable hereunder.
	 
	7.  	CONFIDENTIALITY
	 
	7.1  	Confidential Information. “Confidential Information” means any business or technical
information that a party hereto desires to protect against unauthorized use or disclosure
that: (i) is disclosed in writing and is identified and/or marked by the disclosing party as
Confidential Information at the time of disclosure; or (ii) is disclosed in any other manner
and, under the circumstances of disclosure or due to the
nature of the information, a person exercising reasonable business judgment would understand
to be confidential or proprietary. Without limiting the generality of the foregoing,
Confidential Information may include, but is not limited to, any information relating to
business processes, operations, product plans, designs, costs, product prices and names,
finances, marketing plans, business opportunities, personnel, research, development or
know-how; and the terms and conditions of this Agreement. In addition, for the purpose of
this Agreement: (i) the Transmeta Technology and Transmeta Technology Deliverables and
information disclosed by Transmeta in connection with providing Technology Transfer Training
pursuant to Section 3.1 and Technical Support Services and Maintenance Services pursuant to
Section 3.2 shall be deemed Transmeta’s Confidential Information unless and until such
information falls into any of the exceptions as provided in Section 7.3 below;

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	9
	 	January 2005

 

 

	   	and (ii) any
Sony Improvements that Sony provides to Transmeta pursuant to this Agreement shall be deemed
Sony Confidential Information unless and until such information falls into any of the
exceptions as provided in Section 7.3 below. For the avoidance of doubt, it is acknowledged
and agreed by the parties that Sony has no obligation to disclose Sony Improvements to
Transmeta under this Agreement.
	 
	7.2  	Use and Disclosure Restrictions. Neither party will use the other party’s
Confidential Information except for the purposes of exercising its rights and fulfilling its
obligations hereunder, and will not disclose such Confidential Information to any third party
except to its employees and consultants as is reasonably required in connection with the
exercise of its rights and the fulfillment of its obligations under this Agreement (and, in
case of any consultants, only subject to binding use and disclosure restrictions at least as
protective as those set forth herein to be executed in writing by such consultants). In
addition, Sony may disclose Transmeta’s Confidential Information to any (i) Sony Subsidiary to
which Sony grants a sublicense pursuant to Section 2.2 hereof, (ii) to any third-party
designer or manufacturer of Sony or such a sublicensed Sony Subsidiary for the purpose of
exercising its rights under Section 2.1(b); and (iii) to any third-party customer of Sony or
such a sublicensed Sony Subsidiary for the purpose of exercising its rights under Section 2.1;
provided, that prior to any such disclosure, each such third party customer must execute a
written non-disclosure agreement with Sony that contains use and disclosure restrictions at
least as protective as those set forth herein. Each party will use all reasonable efforts to
protect and to maintain the confidentiality of all of the other party’s Confidential
Information in its possession or control by using the efforts that such party ordinarily uses
with respect to its own proprietary information of similar nature and importance, but in no
event less than reasonable efforts. The foregoing obligations will not restrict either party
from disclosing the terms of this Agreement: (i) pursuant to the order or requirement of a
court, administrative agency, or other governmental body, provided that the party required to
make such a disclosure gives reasonable notice to the other party, to the extent reasonably
practicable, so that the other party may contest such an order or requirement; (ii) on a
confidential basis to its legal or professional financial advisors; (iii) as required under
applicable securities regulations; and (iv) subject to execution of reasonable and customary
written confidentiality agreements consistent with the restrictions set forth herein, to
present or future providers of capital and/or potential acquirers of such party or its assets
associated with the subject matter of this Agreement.
	 
	7.3  	Exclusions. The obligations set forth in Section 7.2 will not apply to any
information that: (i) is or becomes generally known to the public through no fault or breach
of this Agreement by the receiving party; (ii) the receiving party can document was rightfully
known to the receiving party at the time of disclosure without an obligation of
confidentiality; (iii) the receiving party can document was independently developed by the
receiving party without use of the disclosing party’s Confidential Information; or (iv) the
receiving party rightfully obtains from a third party without restriction on use or
disclosure.

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	10
	 	January 2005

 

 

	8.  	OWNERSHIP
	 
	8.1  	Transmeta Ownership. Sony acknowledges and agrees that, as between Transmeta and
Sony, Transmeta owns all right, title, and interest in and to the Transmeta Technology
Deliverables, Transmeta Technology and Transmeta Confidential Information, including all
Intellectual Property Rights therein.
	 
	8.2  	Sony Ownership. Transmeta acknowledges and agrees that, as between Sony and
Transmeta, Sony owns all right, title, and interest in and to the Sony Improvements and Sony
Confidential Information, including all Intellectual Property Rights therein.
	 
	8.3  	Proprietary Notices. Each party will not delete or in any manner alter the patent,
copyright, trademark, and other proprietary rights notices of the other party (and its
suppliers, if any) appearing on the documents (including but not limited to the Transmeta
Technology and/or Transmeta Technology Deliverables, Sony Improvements), as provided or
otherwise made available by the other party hereunder. Each party shall reproduce such
notices on all copies it makes of the documents, as permitted hereunder.
	 
	8.4  	It is acknowledged and agreed by the parties that Sections 8.1 and 8.2 shall not affect each
party’s ownership of any Intellectual Property Rights which exists as of the Effective Date or
will be generated independent of this Agreement thereafter.
	 
	9.  	REPRESENTATIONS AND WARRANTIES
	 
	9.1  	Warranty of Authority. Each party represents and warrants to the other party that it
has the necessary corporate power, right and authority to enter into this Agreement, to carry
out its obligations under this Agreement, and to grant the rights herein granted.
	 
	9.2  	Warranty Disclaimer of Transmeta. EXCEPT AS EXPRESSLY SET FORTH IN SECTION 9.1, TO
THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, TRANSMETA SPECIFICALLY AND EXPRESSLY DISCLAIMS
ANY AND ALL WARRANTIES OR CONDITIONS WITH RESPECT TO THE TRANSMETA TECHNOLOGY, TRANSMETA
TECHNOLOGY DELIVERABLES, TECHNOLOGY TRANSFER TRAINING, TECHNICAL SUPPORT SERVICES AND
MAINTENANCE SERVICES, EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING ANY IMPLIED
WARRANTIES OR CONDITIONS OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, QUALITY, OR
NON-INFRINGEMENT, EVEN IF TRANSMETA HAS BEEN MADE AWARE OF ANY PARTICULAR SONY REQUIREMENTS.
	 
	9.3  	Warranty Disclaimer of Sony. EXCEPT AS EXPRESSLY SET FORTH IN SECTION 9.1, TO THE
FULLEST EXTENT PERMITTED BY APPLICABLE LAW, SONY SPECIFICALLY AND EXPRESSLY DISCLAIMS ANY AND
ALL WARRANTIES OR CONDITIONS REGARDING SONY IMPROVEMENTS, EXPRESS OR IMPLIED, STATUTORY OR
OTHERWISE, INCLUDING ANY

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	11
	 	January 2005

 

 

	   	IMPLIED WARRANTIES OR CONDITIONS OF MERCHANTABILITY, FITNESS FOR A
PARTICULAR PURPOSE, QUALITY, OR NON-INFRINGEMENT, EVEN IF SONY HAS BEEN MADE AWARE OF ANY
PARTICULAR TRANSMETA’S REQUIREMENTS.
	 
	10.  	INFRINGEMENT INDEMNITY
	 
	10.1  	Transmeta Obligations. Subject to Sections 10.2 and 10.4, Transmeta will, at its
expense: (i) defend any third-party action or proceeding brought against Sony (or a Sony
Subsidiary) to the extent that it is based upon a claim that the Transmeta Technology and/or
Transmeta Technology Deliverables, as provided by Transmeta to Sony under this Agreement,
infringes or misappropriates any Intellectual Property Rights of any third party; and (ii)
settle such claim and pay any costs, damages and reasonable attorneys’ fees attributable to
such claim incurred by Sony and/or Sony Subsidiaries in relation to this claim or that are
payable in a settlement approved in advance and in writing, by Transmeta, provided, however,
that Transmeta shall not enter into any settlement that would impose any obligations or
liability upon Sony, without Sony’s prior written consent.
	 
	10.2  	Conditions to Defense Obligations. Transmeta will have no obligations to Sony
under this Section 10 unless Sony: (i) provides Transmeta with prompt written notice of the
claim; (ii) provides Transmeta with all reasonable information and assistance, at Transmeta’s
expense, to defend or settle the claim; and (iii) (subject to the provisos as set forth in
Sections 10.1 (ii)), grants Transmeta authority and sole control of the defense and settlement
of the claim. Sony reserves the right to retain counsel, at Sony’s expense, to participate in
the defense and settlement of any such claim.
	 
	10.3  	Injunctions. If Sony’s use of the Transmeta Technology and/or Transmeta Technology
Deliverables is, or in Transmeta’s opinion is likely to be, enjoined due to a claim of the
type specified in Section 10.1 above, then Transmeta will, at its sole option and expense:
(i) procure for Sony the right to continue using the Transmeta Technology and/or Transmeta
Technology Deliverables under the terms of this Agreement; and/or (ii) replace or modify the
Transmeta Technology and/or Transmeta Technology Deliverables to make it non-infringing but
substantially equivalent in function; or (iii) if options (i) and (ii) above cannot be
accomplished despite Transmeta’s best efforts, then Transmeta and Sony will work together to
determine an mutually agreed-upon alternative solution.
	 
	10.4  	Exclusions. Notwithstanding the terms of Section 10.1, Transmeta will have no
liability for any infringement or misappropriation claim of any kind to the extent it results
from: (i) modifications to the Transmeta Technology or Transmeta Technology Deliverables not
made by Transmeta or a party authorized in writing by Transmeta, if a claim would not have
occurred but for such modifications; (ii) the combination, operation or use of the Transmeta
Technology or Transmeta Technology Deliverables with any data, software, products or devices
not provided by Transmeta or in connection with processes not provided by Transmeta, if a
claim would not have

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	12
	 	January 2005

 

 

	   	occurred but for such combination, operation or use; (iii) Sony’s failure to use updated or
modified versions of the Transmeta Technology or Transmeta Technology Deliverables provided
by Transmeta to avoid a claim; (iv) use of the Transmeta Technology or Transmeta Technology
Deliverables by or on behalf of Sony or any Sony Subsidiary other than in accordance with
this Agreement; or (v) use of the Transmeta Technology or Transmeta Technology Deliverables
in any manner that would cause Transmeta to continue to incur liability to a third party
with respect to an infringement or misappropriation claim after notice from Transmeta to
cease use thereof.
	 
	10.5  	Sole Remedy of Sony. AS BETWEEN TRANSMETA AND SONY, THE PROVISIONS OF THIS SECTION 10
SET FORTH TRANSMETA’S SOLE AND EXCLUSIVE OBLIGATIONS, AND SONY’S SOLE AND EXCLUSIVE REMEDIES,
WITH RESPECT TO ANY THIRD-PARTY INTELLECTUAL PROPERTY RIGHTS INFRINGEMENT OR MISAPPROPRIATION
CLAIMS OF ANY KIND RELATED TO THE TRANSMETA TECHNOLOGY, TRANSMETA TECHNOLOGY DELIVERABLES,
LONGRUN2 PRODUCTS, AND ANY TECHNOLOGY TRANSFER TRAINING, TECHNICAL SUPPORT SERVICES AND
MAINTENANCE SERVICES PROVIDED BY OR FOR TRANSMETA UNDER THIS AGREEMENT.
	 
	11.  	LIMITATION OF LIABILITY
	 
	11.1  	Exclusion of Damages. NEITHER PARTY WILL BE LIABLE FOR ANY INCIDENTAL, SPECIAL,
PUNITIVE, EXEMPLARY OR CONSEQUENTIAL DAMAGES (INCLUDING LOSS OF USE, DATA, BUSINESS, PROFITS,
OR GOODWILL) IN CONNECTION WITH, ARISING OUT OF, OR RELATING TO THIS AGREEMENT OR THE USE OF
THE TRANSMETA TECHNOLOGY, TRANSMETA TECHNOLOGY DELIVERABLES OR FROM TECHNOLOGY TRANSFER
TRAINING, TECHNICAL SUPPORT SERVICES OR MAINTENANCE SERVICES PERFORMED BY TRANSMETA UNDER THIS
AGREEMENT, OR SONY IMPROVEMENTS, WHETHER SUCH LIABILITY ARISES FROM ANY CLAIM BASED UPON
CONTRACT, WARRANTY, TORT (INCLUDING NEGLIGENCE), PRODUCT LIABILITY OR OTHERWISE, AND WHETHER
OR NOT A PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. The foregoing limitation
will not apply to or restrict in any manner: (a) either party’s liability arising from a
breach of Section 7; (b) either party’s liability arising out of any infringement,
misappropriation or violation of the other party’s Intellectual Property Rights; or (c) Sony’s
liability arising from a breach of Section 2.3.
	 
	11.2  	Total Liability. IN NO EVENT WILL EACH OF TRANSMETA’S TOTAL LIABILITY TO SONY AND
SONY’S TOTAL LIABILITY TO TRANSMETA IN CONNECTION WITH, ARISING OUT OF, OR RELATING TO THIS
AGREEMENT, FROM ALL CAUSES OF ACTION AND THEORIES OF LIABILITY, EXCEED * * *. The foregoing
limitation will not apply to or restrict in

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	13
	 	January 2005

 

 

	   	any manner: (a) either party’s liability arising
from a breach of Section 7; (b) either party’s liability arising out of any infringement,
misappropriation or violation of the other party’s Intellectual Property Rights; or (c) Sony’s
liability arising from any breach of Section 2.3.
	 
	11.3  	Acknowledgment. Sony acknowledges that Transmeta has entered into this Agreement in
reliance on the above limitations of liability, and that the same constitute a material basis
of the bargain between the parties. The parties have agreed that the limitations specified
above will survive any expiration or termination of this Agreement and will apply even if any
limited remedy specified in this Agreement is found to have failed of its essential
purpose.
	 
	12.  	GENERAL PROVISIONS
	 
	12.1  	Assignment. Neither party may assign or transfer this Agreement and/or any rights
and/or obligations hereunder, in whole or in part, whether by operation of law or otherwise,
without the other party’s express prior written consent, which consent will not be
unreasonably delayed or withheld; provided that any such assignee or transferee shall agree in
writing to be bound by the terms and conditions of this Agreement. Any attempt to assign or
transfer this Agreement, without such consent, will be null and void and without effect.
Notwithstanding the foregoing, either party may assign or transfer this Agreement, without the
other party’s consent, to a third party that succeeds to all or substantially all of its
assets or related business (whether by sale, merger, operation of law or otherwise), and
Transmeta may so assign this Agreement to an assignee or transferee of, or successor in
interest to, Transmeta’s rights to license the Intellectual Property Rights in and to the
Transmeta Technology; provided that any such assignee, transferee or successor agrees in
writing to be bound by the terms and conditions of this Agreement. Subject to the foregoing,
the rights and obligations of the parties will be binding upon and inure to the benefit of the
parties’ permitted successors and lawful transferees and assigns. Sony agrees, represents and
warrants on behalf of itself and all sublicensed Sony Subsidiaries that it will not transfer
or assign any Patents for which Sony covenants not to sue under Section 2.5, except under
terms and conditions that bind the transferee or assignee to the terms of Section 2.5.
	 
	12.2  	Independent Contractors. In performing their respective duties under this Agreement,
each of the parties will be operating as an independent contractor. Nothing contained herein
will in any way constitute any association, partnership, or joint venture between the parties
hereto. Neither party will have the power to bind the other party or incur obligations on the
other party’s behalf without the other party’s prior written consent.
	 
	12.3  	Equitable Relief. Each party acknowledges and agrees that any breach of this
Agreement with respect to the other party’s Intellectual Property Rights or Confidential
Information may cause such other party to incur irreparable harm and significant injury that
would be difficult to ascertain and would not be compensable

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	14
	 	January 2005

 

 

	   	by damages alone. Accordingly,
each party acknowledges and agrees that, in addition to any and all remedies that the
non-breaching party may have at law or otherwise with respect to such a breach, the
non-breaching party will have the right to obtain specific performance, injunction or other
appropriate equitable relief.
	 
	12.4  	Notice. All notices required or permitted under this Agreement will be in writing
and delivered by confirmed facsimile transmission, by courier or overnight delivery services,
or by certified mail, and in each instance will be deemed given upon receipt. All
communications will be sent to the addresses set forth below or to such other address as may
be specified by either party to the other in accordance with this
Section. Either party may change its address for notices under this Agreement by giving
written notice to the other party by the means specified in this Section.

	 	 	 
	Transmeta:

	 	Sony:
	David R. Ditzel

	 	President
	* * *

	 	SoC Business Group
	 
	 	 
	

	 	Semiconductor Solutions Network Company
	 
	 	 
	3990 Freedom Circle, Santa
Clara, CA 95054, U.S.A.

	 	Shinagawa Seaside Business Center, 4-12-3 Higashishinagawa, Shinagawa-ku, Tokyo 140-0002, Japan
	 
	 	 
	 
	 	 
	

	 	

	 
	 	 
	With a copy to:
	 	 
	John O’Hara Horsley
	 	 
	* * *
	 	 

	12.5  	Compliance with Law; Export Controls. Each party will comply with all laws and
regulations applicable to such party’s performance of this Agreement. Without limiting the
generality of the foregoing, each party will comply fully with all relevant export laws and
regulations of the United States and Japan and all other countries having competent
jurisdiction (“Export Laws”) to ensure that neither the Transmeta Technology, Transmeta
Technology Deliverables nor any direct product thereof or technical data related thereto is:
(i) exported or re-exported directly or indirectly in violation of Export Laws; or (ii) used
for any purposes prohibited by the Export Laws, including, but not limited to, nuclear,
chemical, or biological weapons proliferation.

	12.6  	Waiver. No failure by either party to exercise or enforce any of its rights under
this Agreement will act as a waiver of such rights, and no waiver of a breach in a particular
situation will be held to be a waiver of any other or subsequent breach.

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	15
	 	January 2005

 

 

	12.7  	Severability. If any provision of this Agreement is found invalid or unenforceable,
that provision will be enforced to the maximum extent possible, and the other provisions of
this Agreement will remain in force.
	 
	12.8  	Non-Exclusive Remedy. Except as otherwise set forth in this Agreement, the exercise
by either party of any of its remedies under this Agreement will be without prejudice to its
other remedies under this Agreement or otherwise.
	 
	12.9  	Force Majeure. Neither party will be liable to the other party for any delay or
failure in its performance of this Agreement to the extent that such delay or failure is due
to causes beyond it’s reasonable control, including, but not limited to, acts of God, fires,
earthquake, explosions, labor disputes, war, terrorism, riots, inability to obtain energy or
supplies, provided, that the non-performing party promptly furnishes notice to the other party
and resumes performance as soon as practicable.
	 
	12.10  	Governing Law. This Agreement will be governed by and construed in accordance with
the laws of the State of California. The parties expressly disclaim the application of the
U.N. Convention on Contracts for the International Sale of Goods.
	 
	12.11  	Entire Agreement. This Agreement, including its exhibits, constitutes the complete
and exclusive understanding and agreement between the parties relating to the subject matter
hereof and supersedes all contemporaneous and prior understandings, agreements and
communications (both written and oral) relating to its subject matter. No modifications,
alterations or amendments will be effective unless in writing signed by duly authorized
representatives of both parties.
	 
	12.12  	Publicity. Except as required by applicable law, neither party will individually
make or issue any press release or public statement related to this Agreement or any of the
rights or obligations undertaken by either party hereunder unless agreed otherwise in writing
by both parties prior to the issuance of any such press release or public statement, provided
that if a party is required by applicable law to make or issue any press release or statement,
such party shall immediately notify the other party and both parties shall discuss in good
faith the contents and timing thereof.
	 
	12.13  	Counterparts. This Agreement may be executed in multiple counterparts, each of
which will be deemed an original, but all of which together will constitute one and the same
instrument.
	 
	12.14  	Negotiations. The parties will attempt to resolve all disputes, claims, or
controversies arising under or related to this Agreement or its subject matter or any right or
obligation created by this Agreement (“Dispute”) through good faith negotiations conducted by
the representatives of the parties. The party asserting the Dispute will give prompt notice
to the other party describing the Dispute in reasonable detail (“Dispute Notice”).

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	16
	 	January 2005

 

 

	12.15  	Arbitration. If the parties are unable to resolve a Dispute through good faith
negotiations conducted in accordance with the provisions of Section 12.14 above, then, the
Dispute will be resolved by binding arbitration conducted (i) in Santa Clara County,
California by the American Arbitration Association (“AAA”) in accordance with its Commercial
Arbitration Rules then in effect if Transmeta is the defendant, and (ii) in Tokyo, Japan by
the Japan Commercial Arbitration Association in accordance with its Commercial Arbitration
Rules then in effect if Sony is the defendant. The arbitration will be conducted in the
English language. The number of arbitrators shall be three (3) and they shall be appointed in
accordance with the applicable rules. The award rendered by the arbitrators will be final,
binding and non-appealable. Judgment upon such award may be entered in any court of competent
jurisdiction. All costs incurred in conducting the arbitration (other than fees of counsel)
will be shared equally by the parties.

	12.16  	Reservation of Rights. Notwithstanding the foregoing provision of Section 12.15,
each party reserves the right to seek injunctive or other equitable relief in a court of
competent jurisdiction with respect to any Dispute related to the actual or threatened
infringement, misappropriation or violation of a party’s Intellectual Property Rights or
breach of Section 2 hereof.

     IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by
their duly-authorized representatives as of the Effective Date.

	 	 	 	 	 	 	 
	TRANSMETA CORPORATION:	 	SONY CORPORATION:
	By:

	 	/s/
	 	By:
	 	/s/
	

	 	 
	 	 	 	 
	Name:

	 	Matthew R. Perry
	 	Name:
	 	Masaaki Tsuruta
	

	 	 
	 	 	 	 
	Title:

	 	President and CEO

	 	Title:
	 	President, SOC Business Group

Semiconductor Solutions Network Company 
	Date:

	 	January 20, 2005
	 	Date:
	 	January 18, 2005

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	17
	 	January 2005

 

 

EXHIBIT A

Transmeta Technology and Transmeta Technology Deliverables

The following documents and intellectual property will be delivered substantially in the form
described below, although the exact titles and contents may change. The specific titles and
bulleted descriptions are meant to be indicative of the content of each document.

1. Transmeta LongRun Power Management Overview

     * * *

2. Transmeta LongRun Code Morphing Software Examples

	 	•  	Examples and documentation of * * *

3. Transmeta LongRun Product Engineering Documentation

     * * *

4. Transmeta LongRun Circuit Design Guide

     * * *

5. Transmeta LongRun2 Power Management Overview

     * * *

6. Transmeta LongRun2 * * * Design Guide

     * * *

7. Transmeta LongRun2 Circuit Design Guide

     * * *

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	18
	 	January 2005

 

 

8. Transmeta LongRun2 * * * methodology

     * * *

9. Transmeta LongRun2 Transistor Optimization Guidelines

     * * *

bh

10. Transmeta * * * Design Guide

     * * *

11. Transmeta’s Presentation Materials

	 	•  	Instructional text, PowerPoint slides and other presentation materials used in
connection with the training classes.
	 
	 	•  	Transmeta’s disclosure of Proprietary Information pursuant to that certain Mutual
Non-Disclosure Agreement between Transmeta and Sony, * * *.

12. Transmeta Technology Training

	   	Transmeta will hold training classes for Sony as soon as can be mutually agreed between the
parties, but in no case later than * * * after the Effective Date of this Agreement. Training
classes will cover each of the topic areas listed above. Training classes will take no more
than * * * business days.

13. Additional LongRun2 IP

     * * *

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	19
	 	January 2005

 

 

EXHIBIT B

Maintenance Services and Fees, Technical Support Services and Fees

This exhibit describes the Maintenance Services and Technical Support Services that Transmeta will
provide to Sony pursuant to Section 3.2.

Maintenance Services. Maintenance services to:

(a) evaluate, modify or correct any errors reported by Sony to Transmeta, and

(b) correct or update documentation and/or tangible material, provide bug fixes, or otherwise
maintain the Transmeta Technology, not to exceed * * * per calendar quarter.

Maintenance Services Fee. The fee for Maintenance Services shall be * * * per calendar
quarter (which may be changed by mutual agreement between the parties from time to time). Such
fee will be due and payable * * *. Sony may request an increased level of Maintenance Services
should this not provide sufficient, at an additional rate to be agreed to by the parties.

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	20
	 	January 2005

 

 

Technical Support Services. Pursuant to Section 3.2, Sony may request technical support
services from Transmeta beyond basic Maintenance Services to assist Sony with their
implementation of Transmeta Technology. Such services and fees will be mutually agreed to by
the parties, and may be modified in writing on a quarterly basis.

Below is a description of certain of the types of projects that Transmeta may perform for Sony
as part Technical Support Services, at Sony’s request. The engineering personnel requirements
indicated under “Project Description”, the * * * indicated under “Estimated * * *” for each such
project, and the * * * fee indicated under “Fee * * *” are provided for estimating purposes only
and are not binding on Transmeta or Sony and do not affect the quarterly Technical Support
Service fee payable by Sony, as specified below. The specific services and deliverables (if
any) for each project performed by Transmeta as part of Technical Support Services will be as
mutually agreed to by the parties.

	 	 	 	 	 	 	 
	Project	 	Estimated	 	Fee	 	 
	Description	 	* * *	 	* * *	 	Total
	 
	 
	 	 	 	 	 	 
	Consulting on * * *

	 	* * *
	 	* * *
	 	* * *
	 
	 	 	 	 	 	 
	Consulting on * * *

	 	* * *
	 	* * *
	 	* * *
	 
	 	 	 	 	 	 
	Study project * * *

	 	* * *
	 	* * *
	 	* * *
	 
	 	 	 	 	 	 
	Total

	 	* * *
	 	* * *
	 	* * *

Technical Support Services Fee. The fee for Technical Support Services shall be * * * per
calendar quarter, not to exceed * * * per calendar quarter. Such fee will be due and payable * *
*. Sony may request a different level of Technical Support Services at a rate to be agreed to by
the parties.

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	21
	 	January 2005

 

 

EXHIBIT C

Technology Transfer Service Fees

Technology Transfer Services Fee. Pursuant to Section 3.5, Sony will pay Transmeta a
one-time technology transfer services fee of * * *, as follows:

	 	 	 
	Installment

	 	Due and Payable Date
	 
	 	 
	* * *

	 	within * * * after the execution of this Agreement,
	 
	 	 
	* * *

	 	within * * * after Transmeta’s delivery of all items identified in Sections
1 through 10 of Transmeta Technology Deliverables pursuant to Section 3.1

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	22
	 	January 2005

 

 

EXHIBIT D

Royalties

     For any Licensed LongRun2 Product manufactured by or for Sony, Sony will pay Transmeta
royalties calculated in accordance with the royalty schedule set forth below.

	 	 	 	 	 	 	 	 	 
	 
	 	Cumulative wafers	 	 	Royalty for 8” wafers	 	 	Royalty for 12" or other size wafers	 
	 	* * *
	 	 	* * *
	 	 	* * *	 
	 	* * *
	 	 	* * *
	 	 	* * *	 
	 	* * *
	 	 	* * *
	 	 	* * *	 
	 	* * *
	 	 	* * *
	 	 	* * *	 
	 	* * *
	 	 	* * *
	 	 	* * *	 
	 	* * *
	 	 	* * *
	 	 	* * *	 
	 

Note to Royalty Schedule

	1.  	[* * *].

* * * Confidential treatment has been requested for portions of this exhibit. The copy filed
herewith omits the information subject to the confidential request. Omissions are designated as
* * *. A complete version of this exhibit has been filed separately with the Securities and
Exchange Commission.

 

					
	Sony / Transmeta LongRun2 Agreement
	 	23
	 	January 2005exv10wxeey

 

Exhibit 10(ee)

ANNEX B

LUBY’S, INC.

AMENDED AND RESTATED

NONEMPLOYEE DIRECTOR STOCK PLAN

		
	1. 	Introduction

      This Amended and Restated Nonemployee Director Stock Plan (the “Plan”) of Luby’s, Inc. (the
“Company”), upon approval of the Plan by the shareholders of the Company at their 2005 annual
meeting, shall amend and restate the Nonemployee Director Stock Option Plan first approved by the
shareholders of the Company on January 13, 1995, and subsequently amended on January 14, 1997 and
on January 20, 2000 (the “Original Plan”).

		
	2. 	Effectiveness

      Upon approval of the Plan by the shareholders of the Company at their 2005 annual meeting, the
Plan shall become effective as of the of such meeting, with participants first being allowed to
participate in the Plan at the first meeting of the Board of Directors of the Company following
said annual meeting. If the Plan is not approved by the shareholders at such meeting, it shall not
become effective, and the Original Plan shall continue in force and effect.

		
	3. 	Purpose

      The Purpose of the Plan is to promote the interests of the Company and its shareholders by (a)
promoting a greater identity of interest between the Nonemployee Directors and the Company’s
shareholders and (b) strengthening the Company’s ability to attract and retain the services of
experienced and knowledgeable Nonemployee Directors. To accomplish these objectives, the Plan
authorizes (i) awards of shares of the Company’s common stock par value $.32 per share (“Common
Stock”) which have significant restrictions on sale or transfer prior to vesting to Nonemployee
Directors, (ii) awards of options to purchase shares of Common Stock to Nonemployee Directors, and
(iii) the purchase of shares of Common Stock by Nonemployee Directors out of compensation otherwise
payable to such directors, (collectively, the “Awards”) thereby encouraging such directors to
acquire an increased proprietary interest in the Company.

		
	4. 	Administration

      The Plan shall be administered by the Board of Directors of the Company (the “Board”). The
decision of the Board on any questions concerning the interpretation or administration of the Plan
shall, as between the Company and the Nonemployee Director, be final and conclusive. The Board may
consult with counsel, who may be counsel to the Company, and shall not incur any liability for any
action taken good faith in reliance upon the advice of counsel.

		
	5. 	Participants

      Participants shall be the directors of the Company who are not employees of the Company or a
subsidiary of the Company or any other business entity in which the Company, directly or
indirectly, owns 50% or more of the capital or profit interest (“Nonemployee Directors”).

		
	6. 	Shares

      Subject to the adjustment provisions of Section 10 hereof, the number of shares of Common
Stock of the Company which may be issued connection with Awards available pursuant to the Plan
shall not exceed 400,000 shares. If, however, any Award available under the Plan shall expire,
terminate, or be canceled without having become vested or been exercised in full, the unused shares
shall continue to be available for purposes of the Plan. More than one Award may be granted to the
same participant.

B-1

 

		
	7. 	Restricted Stock

      Each Nonemployee Director shall be eligible to receive shares of restricted Common Stock, in
accordance with the terms of the Plan, as follows:

      (a) On the first day of each January, April, July and October during the term of the Plan,
each Nonemployee Director shall be issued shares of Common Stock bearing such restrictions as
the Board may determine from time to time (“Restricted Stock”) for services as a director of
the Company, in an amount equal to that portion of the annual retainer fee determined by the
Board to be payable in Restricted Stock for the quarterly period beginning on such date, as
such amount may be changed from time to time at the discretion of the Board (the “Mandatory
Retainer Award”).

      (b) On the first day of each January, April, July, and October during the term of the
Plan, each Nonemployee Director shall be issued a number of whole shares of Restricted Stock
equal to the ratio of: (i) a portion of the Director Compensation in excess of the Mandatory
Retainer Award (the “Elective Retainer Award”) for the quarterly period beginning on such date
which the Nonemployee Director has elected pursuant to the provisions of Section 7(f) of the
Plan to be payable in Restricted Stock (expressed as a dollar amount) to (ii) the Fair Market
Value per share of Common Stock on the Stock Award Date (as such terms are defined below). Any
fraction of a share shall be disregarded and the remaining amount of the Director Compensation
shall be paid in cash.

      (c) On the first day of each January, April, July, and October during the term of the
Plan, each Nonemployee Director who has elected pursuant to the provisions of the Plan to
receive Restricted Stock in payment of the Elective Retainer Award, shall be granted an
additional number of whole shares of Restricted Stock equal to twenty percent (20%) of the
number of whole shares of Restricted Stock issued in payment of the Elective Retainer Award for
the quarterly period beginning on such date.

      (d) Upon the date of election, each newly elected Nonemployee Director (i.e., a
Nonemployee Director who has not previously served as a director of the Company) shall be
granted the number of shares of Restricted Stock designated by resolution of the Board for such
persons from time to time.

      (e) The term “Fair Market Value” as used in this Plan means with respect to any date, the
average between the highest and lowest sale prices per share of Common Stock on the New York
Stock Exchange Composite Transactions Tape on such date, provided that if there shall be no
sales of shares of Common Stock reported on such date, the Fair Market Value of a share of
Common Stock on such date shall be deemed to be equal to the average between the highest and
lowest sale prices per share on such composite tape for the last preceding date on which sales
of shares of Common Stock were reported. In the event that Shares are not traded on the New
York Stock Exchange as of a given date, the Fair Market Value of a Share as of such date shall
be established by the Board acting in good faith. The term “Stock Award Date” means the date on
which shares of Restricted Stock are granted to a Nonemployee Director. The term “Director
Compensation” means all cash compensation payable to a Nonemployee Director for services as a
director of the Company.

      (f) Each Nonemployee Director who, prior to the end of any calendar year during the Term
of the Plan files with the Board or its designee a written election to receive an Elective
Retainer Award. An election pursuant to this Section 7.(f) shall be irrevocable.

      (g) Upon an award of shares of Restricted Stock to a Nonemployee Director, the stock
certificate representing such shares of Common Stock shall be issued and transferred to the
Nonemployee Director, whereupon the Nonemployee Director shall become a stockholder of the
Company with respect to such shares and shall be entitled to vote the shares; provided,
however, subject to the provisions of Section 11, no such shares shall be transferable by the Nonemployee Director
for a period of three (3) years from the Stock Award Date.

B-2

 

		
	8. 	Options

      (a) The Board shall select the Nonemployee Directors who are to be granted Options under the
Plan and, subject to the provisions of the Plan, shall determine the terms, conditions, and
limitations applicable to each Option. No Nonemployee Director may receive, under the Plan, Options
for more than 5,000 shares in any 12-month period.

      (b) The option price shall be 100% of the Fair Market Value of the shares at the time of the
granting of the Option. Such Fair Market Value shall be determined by the Board pursuant to the
provisions of Section 7.(e) hereof.

      (c) (i) An Option shall terminate upon the expiration of ten years from the date the Option is
granted or one year from the date the optionee ceases to be a director of the Company, whichever
first occurs (the “Expiration Date”). In no event shall an Option be exercised after the Expiration
Date.

      (ii) To the extent that an Option is exercisable, it may be exercised by the optionee or
the legal representative of the optionee or the legal representative of the optionee’s estate.
Except as provided in subsection (c)(iii) below, an Option may not be exercised prior to the
expiration of one year from the date the Option is granted. Once an Option becomes exercisable,
it may thereafter be exercised, wholly or in part, at any time prior to its Expiration Date.

      (iii) Upon the occurrence of any of the following events prior to the Expiration Date of
an Option, the Option shall become immediately and fully exercisable:

      A. death of the optionee;

      B. resignation or removal of the optionee as a director of the Company by reason of a
physical or mental impairment which prevents the optionee from performing the duties of his
or her directorship for a period of six months or more;

      C. resignation of the optionee as a director of the Company after having served at
least two full terms as a director; or

      D. expiration of the optionee’s term of office as a director of the Company, without
being reelected to the Board, after having served at least two full terms as a director.

No Option shall be assignable or transferable other than by will or the laws of descent and
distribution. During an optionee’s lifetime, only the optionee or his or her guardian or legal
representative may exercise an option.

      (d) Payment for shares purchased upon exercise of an Option shall be made in full at the time
of exercise of the Option. No loan shall be made or guaranteed by the Company for the purpose of
financing the purchase of any optioned shares. Payment of the option price shall be made in cash,
or by delivering Common Stock of the Company having a Fair Market Value (determined as provided in
Section 7.(e)) at least equal to the option price, or a combination of Common Stock and cash.
Payment in shares of Common Stock shall be made by delivering to the Company certificates, duly
endorsed for transfer, representing shares of Common Stock having an aggregate Fair Market Value on
the date of exercise equal to that portion of the option price which is to be paid in Common Stock.
Whenever payment of the option price would require delivery of a fractional share, the optionee
shall deliver the next lower whole number of shares of Common Stock and a cash payment shall be
made by the optionee for the balance of the option price.

      (e) Options granted under the Plan do not meet the requirements of Section 422 of the Internal
Revenue Code and are commonly referred to as “nonqualified stock options.”

		
	9. 	Listing and Registration

      The Company, in its discretion, may postpone the issuance and delivery of shares issuable in
connection with an Award, until completion of such stock exchange listing, or registration, or
other qualification of such shares under any federal or state law, rule, or regulation, as the
Company may consider appropriate. The Company may require any person entitled to shares issuable in
connection with an Award to make such

B-3

 

representations and to furnish such information as the Company may consider appropriate in
connection with the issuance of the shares in compliance with applicable law.

		
	10. 	Adjustment Provisions

      (a) If the Company shall at any time change the number of issued shares of Common Stock
without new consideration to the Company (such as by stock dividend, stock split, recapitalization,
reorganization, exchange of shares, liquidation, combination or other change in corporate structure
affecting the Common Stock) or make a distribution of cash or property which has a substantial
impact on the value of issued shares of Common Stock, the total number of shares of Common Stock
reserved for issuance under the Plan shall be appropriately adjusted and the number of shares of
Common Stock covered by each outstanding Option and the purchase price per share under each
outstanding Option shall be adjusted so that the aggregate consideration payable to the Company and
the value of each such Option shall not be changed.

      (b) Notwithstanding any other provision of the Plan, and without affecting the number of
shares reserved or available hereunder, the Board shall authorize the issuance, continuation or
assumption of outstanding Options or provide for other equitable adjustments after changes in the
shares of Common Stock resulting from any merger, consolidation, sale of assets, acquisition of
property or stock, recapitalization, reorganization or similar occurrence in which the Company is
the continuing or surviving Company, upon such terms and conditions as it may deem necessary to
preserve the rights of Optionees and holders of shares of Common Stock that are subject to any
restrictions under the Plan.

      (c) In the case of any sale of assets, merger, consolidation or combination of the Company
with or into another Company other than a transaction in which the Company is the continuing or
surviving Company and which does not result in the outstanding Common Stock being converted into or
exchanged for different securities, cash or other property, or any combination thereof (an
“Acquisition”), any Optionee who holds an outstanding Option shall have the right (subject to the
provisions of the Plan and any limitation applicable to the Option) thereafter and during the term
of the Option, to receive upon exercise thereof the Acquisition Consideration (as defined below)
receivable upon the Acquisition by a holder of the number of shares of Common Stock which would
have been obtained upon exercise of the Option or portion thereof, as the case may be, immediately
prior to the Acquisition. The term “Acquisition Consideration” shall mean the kind and amount of
shares of the surviving or new Company, cash, securities, evidence of indebtedness, other property
or any combination thereof receivable in respect of one share of Common Stock upon consummation of
an Acquisition.

		
	11. 	Change of Control

      (a) Upon the occurrence of an event of “Change of Control”, as defined below, any and all
outstanding Options shall become immediately vested and exercisable and any and all stock
certificates representing shares awarded to a Nonemployee Director pursuant to the provisions of
Section 7 hereof, shall be transferred to such Nonemployee Director.

      (b) A “Change of Control” shall occur when:

      (i) A “Person” (which term, when used in this Section 11, shall have the meaning it has
when it is used in Section 13(d) of the Securities Exchange Act of 1934, as amended, (the
“Exchange Act”), but shall not include the Company, any underwriter temporarily holding
securities pursuant to an offering of such securities, any trustee or other fiduciary holding
securities under an employee benefit plan of the Company, or any Company owned, directly or
indirectly, by the stockholders of the Company in substantially the same proportions as their
ownership of Voting Stock (as defined below) of the Company) is or becomes, without the prior
consent of a majority of the Continuing Directors (as defined below), the Beneficial Owner (as
defined in Rule 13d-3 promulgated under the Exchange Act), directly or indirectly, of Voting Stock (as defined below) representing twenty percent
(20%) or more of the combined voting power of the Company’s then outstanding securities; or

B-4

 

      (ii) The stockholders of the Company approve and the Company consummates a reorganization,
merger or consolidation of the Company or the Company sells, or otherwise disposes of, all or
substantially all of the Company’s property and assets, or the Company liquidates or dissolves
(other than a reorganization, merger, consolidation or sale which would result in all or
substantially all of the beneficial owners of the Voting Stock of the Company outstanding
immediately prior thereto continuing to beneficially own, directly or indirectly (either by
remaining outstanding or by being converted into voting securities of the resulting entity),
more than fifty percent (50%) of the combined voting power of the voting securities of the
Company or such entity resulting from the transaction (including, without limitation, an entity
which as a result of such transaction owns the Company or all or substantially all of the
Company’s property or assets, directly or indirectly) outstanding immediately after such
transaction in substantially the same proportions relative to each other as their ownership
immediately prior to such transaction): or

      (iii) The individuals who are Continuing Directors of the Company (as defined below) cease
for any reason to constitute at least a majority of the Board of the Company.

      (iv) For purposes of this Section 11, (i) the term “Continuing Director” means (A) any
member of the Board who is a member of the Board immediately after the issuance of any class of
securities of the Company that are required to be registered under Section 12 of the Exchange
Act, and the term “Voting Stock” means all capital stock of the Company which by its terms may
be voted on all matters submitted to shareholders of the Company.

		
	12. 	Provision for Taxes

      It shall be a condition to the Company’s obligation to issue or reissue shares of Common Stock
in connection with an Award that the participant pay, or make provision satisfactory to the Company
for payment of, any federal or state income or other taxes which the Company is obligated to
withhold or collect with respect to the issuance or reissuance of such shares.

		
	13. 	Term of Plan

      Subject to the provisions of Section 15 hereof, the Plan shall continue in effect until the
maximum number of shares of Common Stock issuable under the Plan has been issued.

		
	14. 	Restrictions on Exercise

      Any provision of the Plan to the contrary notwithstanding, (i) no Option granted pursuant to
the Plan shall be exercisable at any time, in whole or in part, prior to the shares of Common Stock
subject to the Option being authorized for listing on the New York Stock Exchange and (ii) no
Option granted pursuant to the Plan shall be exercisable at any time, nor shall any shares of
Restricted Stock issuable pursuant to the Plan be issued, if issuance and delivery of the shares of
Common Stock subject to the Award would be in violation of any applicable laws or governmental
regulations.

		
	15. 	Amendment and Termination

      Subject to the limitation that the provisions of the Plan shall not be amended more than once
every six months other than to comport with changes in the Internal Revenue Code, the Employee
Retirement Income Security Act, applicable securities laws and applicable stock exchange
regulations, or the rules thereunder, the Board may at any time amend, suspend or discontinue the
Plan or alter or amend any or all Awards under the Plan to the extent permitted by law. However, no
such action by the Board may, without approval of the shareholders of the Company, alter the
provisions of the Plan so as to:

      (a) increase the maximum number of shares of Common Stock that may be issued in connection
with Awards granted under the Plan except pursuant to Section 10;

      (b) change the class of individuals eligible to receive Awards under the Plan; or

B-5

 

      (c) effect any other amendment to the Plan for which approval of the Company’s
shareholders is required by Rule 16b-3 under the Exchange Act, or as a condition to the listing
of shares on the NYSE.

		
	16. 	Unfunded Plan

      The Plan shall be unfunded. Neither the Company nor the Board shall be required to segregate
any assets in connection with Awards issued pursuant to the Plan. Any liability of the Company to
any Nonemployee Director with respect to an Award shall be based solely upon contractual
obligations created by the Plan and any Award agreement. No such obligation shall be deemed to be
secured by any pledge or any encumbrance on any property of the Company.

		
	17. 	Governing Law

      This Plan shall be governed by, construed, and enforced in accordance with the internal laws
of the State of Delaware, and, where applicable, the laws of the United States.

B-6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}]]